Announcements Trials
Browse Landscape

Status

Completed 6Recruiting 4Unknown 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Plasma cell 1Other solid neoplasm 1

Conditions

Multiple Myeloma 1Metastatic Solid Tumor Cancers 1

Interventions

pembrolizumab 223Cyclophosphamide 192Radiotherapy 183Nivolumab 181Carboplatin 153Cisplatin 114Paclitaxel 112Dexamethasone 110Radiosurgery 103Magnetic Resonance Spectroscopy 97Surveys and Questionnaires 90Ipilimumab 81Doxorubicin 79Lenalidomide 76Rituximab 75durvalumab 74atezolizumab 72Radiation 72fludarabine 68Standard of Care 68Gemcitabine 68venetoclax 67Specimen Handling 65Etoposide 64Capecitabine 64Bevacizumab 62Oxaliplatin 59Docetaxel 58Biopsy 58Radiotherapy, Intensity-Modulated 56

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × OTHER × 4-amino-4'-hydroxylaminodiphenylsulfone × Clear all
NCT06126341 2026-02-19

A Study to Identify Barriers to Cellular Therapies for People With Plasma Cell Disorders

Memorial Sloan Kettering Cancer Center

Active not recruiting
49 enrolled
Plasma cell

Multiple Myeloma

NCT03667378 2025-10-28

Investigating the Impact of Proactive Palliative Care

Memorial Sloan Kettering Cancer Center

Active not recruiting
83 enrolled
Other solid neoplasm

Metastatic Solid Tumor Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡